Annual Total Liabilities:
$319.06M+$68.25M(+27.21%)Summary
- As of today, NTLA annual total liabilities is $319.06 million, with the most recent change of +$68.25 million (+27.21%) on December 31, 2024.
- During the last 3 years, NTLA annual total liabilities has risen by +$64.84 million (+25.51%).
- NTLA annual total liabilities is now at all-time high.
Performance
NTLA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Liabilities:
$176.85M-$6.79M(-3.70%)Summary
- As of today, NTLA quarterly total liabilities is $176.85 million, with the most recent change of -$6.79 million (-3.70%) on September 30, 2025.
- Over the past year, NTLA quarterly total liabilities has dropped by -$33.88 million (-16.08%).
- NTLA quarterly total liabilities is now -44.57% below its all-time high of $319.06 million, reached on December 31, 2024.
Performance
NTLA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NTLA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +27.2% | -16.1% |
| 3Y3 Years | +25.5% | -31.9% |
| 5Y5 Years | +395.4% | +37.2% |
NTLA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +27.2% | -44.6% | at low |
| 5Y | 5-Year | at high | +395.4% | -44.6% | +37.2% |
| All-Time | All-Time | at high | >+9999.0% | -44.6% | +1157.7% |
NTLA Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $176.85M(-3.7%) |
| Jun 2025 | - | $183.64M(-11.0%) |
| Mar 2025 | - | $206.24M(-35.4%) |
| Dec 2024 | $319.06M(+27.2%) | $319.06M(+51.4%) |
| Sep 2024 | - | $210.74M(-4.4%) |
| Jun 2024 | - | $220.47M(-1.3%) |
| Mar 2024 | - | $223.45M(-10.9%) |
| Dec 2023 | $250.81M(-11.9%) | $250.81M(+21.8%) |
| Sep 2023 | - | $205.94M(-5.7%) |
| Jun 2023 | - | $218.35M(-3.8%) |
| Mar 2023 | - | $227.05M(-20.2%) |
| Dec 2022 | $284.53M(+11.9%) | $284.53M(+9.6%) |
| Sep 2022 | - | $259.51M(+12.9%) |
| Jun 2022 | - | $229.88M(-7.7%) |
| Mar 2022 | - | $249.03M(-2.0%) |
| Dec 2021 | $254.22M(+70.3%) | $254.22M(+11.6%) |
| Sep 2021 | - | $227.86M(+28.4%) |
| Jun 2021 | - | $177.43M(+3.7%) |
| Mar 2021 | - | $171.02M(+14.6%) |
| Dec 2020 | $149.25M | $149.25M(+15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $128.94M(-7.4%) |
| Jun 2020 | - | $139.24M(+107.8%) |
| Mar 2020 | - | $66.99M(+4.0%) |
| Dec 2019 | $64.40M(-7.2%) | $64.40M(-9.3%) |
| Sep 2019 | - | $70.98M(-6.1%) |
| Jun 2019 | - | $75.58M(-5.6%) |
| Mar 2019 | - | $80.03M(+15.3%) |
| Dec 2018 | $69.39M(-8.3%) | $69.39M(+19.7%) |
| Sep 2018 | - | $57.96M(-4.1%) |
| Jun 2018 | - | $60.44M(-5.6%) |
| Mar 2018 | - | $64.05M(-15.3%) |
| Dec 2017 | $75.64M(-15.1%) | $75.64M(+3.2%) |
| Sep 2017 | - | $73.32M(-5.3%) |
| Jun 2017 | - | $77.39M(-2.5%) |
| Mar 2017 | - | $79.38M(-10.9%) |
| Dec 2016 | $89.13M(+502.9%) | $89.13M(+6.9%) |
| Sep 2016 | - | $83.34M(-4.2%) |
| Jun 2016 | - | $87.02M(+518.8%) |
| Mar 2016 | - | $14.06M(-86.4%) |
| Dec 2015 | $14.78M(+372.6%) | $103.34M |
| Dec 2014 | $3.13M | - |
FAQ
- What is Intellia Therapeutics, Inc. annual total liabilities?
- What is the all-time high annual total liabilities for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly total liabilities?
- What is the all-time high quarterly total liabilities for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Intellia Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of NTLA is $319.06M
What is the all-time high annual total liabilities for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual total liabilities is $319.06M
What is Intellia Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, NTLA annual total liabilities has changed by +$68.25M (+27.21%)
What is Intellia Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of NTLA is $176.85M
What is the all-time high quarterly total liabilities for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly total liabilities is $319.06M
What is Intellia Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, NTLA quarterly total liabilities has changed by -$33.88M (-16.08%)